Identification of Barriers Preventing Biosimiliar Oncology Medication Adoption

oncology, cancer, biosimilar, barriers, access, obstacles

Biosimilars are biologic medical products that are almost identical to original biologics but are produced by different companies. They are safe, effective, and can reduce costs for insurers and patients. Despite the benefits, barriers exist for oncologists and cancer centers in prescribing biosi…

Oct 27^th • 30 mins read